Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely ...

TORONTO, Nov. 4, 2025 /CNW/ – This November, in honour of Crohn’s and Colitis Awareness Month, Crohn’s and Colitis Canada is spotlighting the courage and resilience of children and youth living ...

Ustekinumab and vedolizumab have comparable safety and efficacy in older and younger adults with IBD, indicating that age should not be a deterrent for treatment.

Cash and Cash Equivalents: As of September 30, 2025, Kymera had $978.7 million in cash, cash equivalents and investments. Kymera expects that its cash balance will provide the Company with a cash ...

Jordie Poncy was about to start his dream job as a psychologist at the Moffitt Cancer Center. Then he entered Moffitt as a patient himself.

Donga CHAMMED, a subsidiary of Dong-A ST, announced on the 4th that it participated in the '2025 Korean Society for Laboratory Medicine International ...

At-home gut microbiome tests are trending, selling insights to the curious, empowerment to the chronically ill and a claimed ...

At the next visit, his wife asked me about the potential causes of chronic inflammation that she’d read about online—tick ...

World-renowned colorectal surgeon Steven Wexner, MD, has joined MedStar Health as physician executive director and system chief of Colorectal ...

Update on WTX-124 Phase 1/1b clinical trial interim data and End of Phase 1 meeting with the U.S. Food & Drug Administration (FDA) is ...

Juicing is a fantastic way to support your body as you age, but juicing alone won’t stop wrinkles or inflammation. Learn the ...

Sarepta stock crashed Tuesday after the biotech company said two of its muscular dystrophy drugs failed confirmatory tests.